Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Food Chem Toxicol ; 48(8-9): 2298-303, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20573577

RESUMO

Anti-atherogenic effect of ferulic acid (0.02%, w/w) was investigated in comparison with the clofibrate (0.02%, w/w) in apolipoprotein E-deficient (apo E(-/-)) mice fed Western diet. Concentrations of total cholesterol (total-C), apolipoprotein B (apo B) in the plasma and epididymal adipose tissue weight were significantly lower in the ferulic acid and clofibrate supplemented groups compared to the control group. The ratio of apo B to apo A-I was also significantly lower in those groups than in the control group. Activities of hepatic ACAT and HMG-CoA reductase were only significantly lower in the ferulic acid and clofibrate groups, respectively than in the control group. The numbers of mice that exhibited aortic fatty plaque were 8/10 in control groups vs. 0/10 in the ferulic acid or clofibrate group. The activities of anti-oxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and paraoxonase) in the hepatocyte and erythrocyte were significantly higher in the ferulic acid group than in the control group. In contrast, hepatic TBARS level was only markedly lower in the ferulic acid group. These results provide a new insight into the anti-atherogenic property of ferulic acid in the apo E(-/-) mice fed a Western diet.


Assuntos
Anticolesterolemiantes/farmacologia , Apolipoproteínas E/genética , Aterosclerose/prevenção & controle , Clofibrato/farmacologia , Ácidos Cumáricos/farmacologia , Dieta , Tecido Adiposo/efeitos dos fármacos , Animais , Antioxidantes/farmacologia , Apolipoproteínas E/fisiologia , Arildialquilfosfatase/metabolismo , Aterosclerose/patologia , Ingestão de Alimentos/efeitos dos fármacos , Hidroximetilglutaril-CoA Redutases/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Lipídeos/sangue , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Tamanho do Órgão/efeitos dos fármacos , Esterol O-Aciltransferase/metabolismo , Aumento de Peso/efeitos dos fármacos
2.
Food Chem Toxicol ; 44(11): 1875-83, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16904806

RESUMO

The objective of this study was to investigate the hypolipidemic effects of powdered whole persimmon leaf supplement in rats fed high-fat diet. Three groups of male Sprague-Dawley rats during 6 weeks were fed different diet: normal control (NC), high-fat (HF), and high-fat supplemented with powdered whole persimmon leaf (PL; 5%, wt/wt) groups. Body weight and relative weight of interscapular brown adipose tissue were significantly lower in the PL group than in the HF group, while plasma leptin concentration was higher. The supplementation of persimmon leaf significantly lowered the plasma total cholesterol and triglyceride concentrations, whereas elevated the ratio of HDL-C/total-C and improved the atherogenic index. Persimmon leaf supplementation led the hepatic cholesterol and triglyceride values to similar levels to the NC group. Accumulation of hepatic lipid droplets and the epididymal white adipocyte size of PL group were diminished comparing to the HF group. Hepatic HMG-CoA and ACAT activities were significantly higher in the PL group than in other groups. Contents of fecal triglyceride, cholesterol and acidic sterol were significantly higher in the PL group than in the HF group. Accordingly, we suggest that supplementation of the powdered whole persimmon leaf improves plasma and hepatic lipid levels profile partly via the increased fecal lipids in high-fat fed rats. These beneficial effects may be due to the properties of its phenolic compounds (1.15 g/100g) and high fiber (63.48 g/100g) content in the powdered persimmon leaf.


Assuntos
Gorduras na Dieta/administração & dosagem , Diospyros/química , Hipolipemiantes/farmacologia , Metabolismo dos Lipídeos/efeitos dos fármacos , Extratos Vegetais/farmacologia , Aumento de Peso/efeitos dos fármacos , Acil Coenzima A/metabolismo , Tecido Adiposo Marrom/efeitos dos fármacos , Animais , Colesterol/sangue , Colesterol/metabolismo , Modelos Animais de Doenças , Epididimo/efeitos dos fármacos , Epididimo/patologia , Lipoproteínas/sangue , Lipoproteínas/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Masculino , Tamanho do Órgão/efeitos dos fármacos , Folhas de Planta/química , Ratos , Ratos Sprague-Dawley , Esterol O-Aciltransferase/metabolismo , Triglicerídeos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...